The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 138.00
Bid: 138.80
Ask: 139.00
Change: -4.60 (-3.23%)
Spread: 0.20 (0.144%)
Open: 142.20
High: 142.20
Low: 137.20
Prev. Close: 138.00
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of advantaged manufacturing site in India

20 Dec 2018 15:11

ELEMENTIS PLC - Acquisition of advantaged manufacturing site in India

ELEMENTIS PLC - Acquisition of advantaged manufacturing site in India

PR Newswire

London, December 20

20 December 2018

Elementis plc

Acquisition of advantaged manufacturing site in India

Elementis plc (“Elementis” or the “Group”), a global specialty chemicals company, is pleased to announce that it has, through Elementis Specialties (India) Private Limited, entered into an agreement to acquire a production facility in Mumbai, India.

Elementis identified growth in Asia as a key priority in its Reignite Growth strategy. This investment in India represents an important step in the execution of these plans. The production facility we have identified is well located in a premium industrial chemical zone and represents an excellent opportunity for Elementis to establish an advantaged manufacturing presence in a key growth market and realise global supply chain efficiencies. 

The site will be acquired for approximately $4m and over the next two years we expect to invest a further $15m in the facility to enable production of additives for the Personal Care, Coatings and Energy markets. The facility will provide a well invested base to serve both India and other fast growing markets in Asia.

The acquisition and subsequent investment will be funded within existing capital expenditure plans.

Commenting on the acquisition, Elementis CEO, Paul Waterman said,

“This is an exciting step for the development of Elementis in Asia. Establishing a direct presence in India will allow Elementis to bring distinctive technology to the market and enable us to strengthen our proposition to customers both in India and beyond. This investment will support our ambitious growth plans in Asia over the coming years which is a key part of our Reignite Growth strategy.”

Enquiries

James Curran, Investor Relations Tel: 020 7067 2994

Martin Robinson/David Allchurch, Tulchan Tel: 020 7353 4200

Date   Source Headline
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration
9th Mar 20232:50 pmRNSDirector/PDMR Shareholding
9th Mar 20232:47 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSPreliminary results year ended 31 December 2022
1st Mar 20239:53 amRNSBlock listing Interim Review
1st Mar 20239:39 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.